# Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma

> **NCT02178280** · PHASE1,PHASE2 · UNKNOWN · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 60 (estimated)

## Conditions studied

- Hilar Cholangiocarcinoma

## Interventions

- **OTHER:** liver transplantation combined with neoadjuvant therapy

## Key facts

- **NCT ID:** NCT02178280
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02178280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02178280, "Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02178280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*